We are live on
!
Find out more
CA
Cornerstone Advisors Portfolio holdings
AUM
$3.04B
Turnover
28.46%
1-Year Est. Return
36.62%
This Fund
S&P 500
This Quarter
Est. Return
-16.14%
1 Year Est. Return
+36.62%
3 Year Est. Return
+108.19%
5 Year Est. Return
+137.76%
10 Year Est. Return
–
AUM
$1.91B
AUM Growth
+$209M
(+12%)
Cap. Flow
+$552M
Cap. Flow
% of AUM
28.97%
Top 10 Holdings %
Top 10 Hldgs %
32.5%
Holding
202
New
39
Increased
84
Reduced
21
Closed
13
Avg Time Held
1.8
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.8M |
| 2 |
Apple
AAPL
|
+$23.8M |
| 3 |
Tesla
TSLA
|
+$22.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$21.3M |
| 5 |
Pfizer
PFE
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$15M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$11.6M |
| 3 |
Medtronic
MDT
|
+$8.1M |
| 4 |
Eli Lilly
LLY
|
+$7.71M |
| 5 |
TRI-Continental Corp
TY
|
+$7.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Healthcare | 15.78% |
| 3 | Financials | 13.4% |
| 4 | Miscellaneous | 12.16% |
| 5 | Consumer Discretionary | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Cohen & Steers REIT and Preferred and Income Fund
RNP
$889M
| $862K | 0.05% |
+40,391
| New | +$944K |
2022 Q2
0 quarters
|
|
177
American Electric Power
AEP
$68.7B
| $796K | 0.04% |
+8,300
| New | +$823K |
2022 Q2
0 quarters
|
|
|
178
TRI-Continental Corp
TY
$1.86B
| $796K | 0.04% |
30,416
-259,105
| -89% | -$7.44M |
2021 Q1
5 quarters
|
|
179
Southwest Airlines
LUV
$20.1B
| $650K | 0.03% |
18,000
-33,000
| -65% | -$1.42M |
2021 Q2
4 quarters
|
|
180
Occidental Petroleum
OXY
$61.3B
| $630K | 0.03% |
+10,700
| New | +$657K |
2022 Q2
0 quarters
|
|
181
Bank of New York Mellon
BNY
$97.8B
| $626K | 0.03% |
15,000
| – | – |
2021 Q2
4 quarters
|
|
182
Valero Energy
VLO
$128B
| $616K | 0.03% |
+5,800
| New | +$687K |
2022 Q2
0 quarters
|
|
183
Colgate-Palmolive
CL
$74.6B
| $545K | 0.03% |
+6,800
| New | +$532K |
2022 Q2
0 quarters
|
|
184
HP
HPQ
$27.5B
| $459K | 0.02% |
14,000
| – | – |
2021 Q1
5 quarters
|
|
185
abrdn Global Dynamic Dividend Fund
AGD
$294M
| $441K | 0.02% |
+47,071
| New | +$474K |
2022 Q2
0 quarters
|
|
186
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$115M
| $377K | 0.02% |
34,187
-10,602
| -24% | -$132K |
2016 Q1
25 quarters
|
|
187
New Germany Fund
GF
$168M
| $211K | 0.01% |
25,023
-9,810
| -28% | -$97.6K |
2020 Q4
6 quarters
|
|
188
abrdn Life Sciences Investors
HQL
$515M
| $192K | 0.01% |
+13,500
| New | +$204K |
2022 Q2
0 quarters
|
|
189
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
| $107K | 0.01% |
+13,200
| New | +$115K |
2022 Q2
0 quarters
|
|
190
Archer Daniels Midland
ADM
$40.1B
| – | – |
-15,000
| Closed | -$1.35M | – |
|
191
DexCom
DXCM
$33.3B
| – | – |
-4,000
| Closed | -$512K | – |
|
192
Ecolab
ECL
$81.9B
| – | – |
-13,000
| Closed | -$2.29M | – |
|
193
Idexx Laboratories
IDXX
$44.1B
| – | – |
-2,000
| Closed | -$1.09M | – |
|
|
JEQ
194
DELISTED
abrdn Japan Equity Fund
JEQ
| – | – |
-54,746
| Closed | -$381K | – |
|
|
195
Medtronic
MDT
$122B
| – | – |
-73,000
| Closed | -$8.1M | – |
|
196
Moderna
MRNA
$86.6B
| – | – |
-5,000
| Closed | -$861K | – |
|
197
Mexico Fund
MXF
$296M
| – | – |
-10,058
| Closed | -$167K | – |
|
198
Northrop Grumman
NOC
$73.1B
| – | – |
-14,000
| Closed | -$6.26M | – |
|
199
Swiss Helvetia Fund
SWZ
$75.2M
| – | – |
-38,322
| Closed | -$353K | – |
|
200
Stryker
SYK
$114B
| – | – |
-26,000
| Closed | -$6.95M | – |
|
Similar funds
GFA
SL
JFGIW
Cornerstone Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Cornerstone Advisors held 202 positions worth $1.91B, up 12% from $1.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Cornerstone Advisors deployed $552M of net new capital in Q2 2022, opening 39 new positions and adding to 84 existing holdings. Its largest new stake was Pfizer: 410,100 shares worth $21.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Procter & Gamble, an estimated $15M trimmed.
- Cornerstone Advisors's largest Q2 2022 buy was Pfizer: 410,100 shares worth $21.5M.
- Cornerstone Advisors added most to Microsoft in Q2 2022, an estimated $25.8M increase.
- Cornerstone Advisors's biggest Q2 2022 reduction was Procter & Gamble, cutting an estimated $15M.
- Cornerstone Advisors fully exited Medtronic in Q2 2022, selling an estimated $8.1M.
- Cornerstone Advisors's ten largest holdings make up 33% of its $1.91B portfolio in Q2 2022.
- Cornerstone Advisors opened 39 new positions and closed 13 in Q2 2022.
- Cornerstone Advisors's portfolio value rose 12% quarter-over-quarter to $1.91B.
Based on Cornerstone Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.